MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Treatment"

  • 2024 International Congress

    Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis

    M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)

    Objective: To compare upper limb spasticity (ULS) severity changes from baseline in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA (incoA)…
  • 2024 International Congress

    Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis

    M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)

    Objective: To compare changes from baseline in upper limb spasticity (ULS) severity in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA…
  • 2024 International Congress

    Identifying and Managing Spasticity in Neurological Shoulder Dysfunction

    D. Hoad, S. Ashford, G. Bavikatte, R. Farrell, A. Robertson, J. Wissel (Coventry, United Kingdom)

    Objective: To understand this discrepancy between diagnosis and treatment of spasticity in neurological shoulder dysfunction, we formed an expert panel to establish consensus and provide…
  • 2024 International Congress

    Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: Results from the AboLiSh real world observational study

    A. Esquenazi, R. Zorowitz, S. Ashford, M. Beneteau, P. Maisonobe, C. Hannes, J. Jacinto (Elkins Park, USA)

    Objective: Assess longitudinal goal attainment with repeated injections of abobotulinumtoxinA (aboBoNT-A) in the lower-limb over 16-months in a routine clinical setting. Background: While the efficacy…
  • 2024 International Congress

    Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real world practice

    R. Zorowitz, J. Jacinto, S. Ashford, M. Beneteau, P. Maisonobe, C. Hannes, A. Esquenazi (Washington, USA)

    Objective: Describe abobotulinumtoxinA (aboBoNT-A) dosing parameters for the most currently targeted muscles in the routine management of lower limb spasticity. Background: The efficacy and safety…
  • 2023 International Congress

    Quantitative gait analysis to evaluate changes in gait pattern after Botulinum toxin A injection by hemiparesis

    M. Pinter, M. Petrovicsova, Y. Teuschl, A. Dachenhausen, K. Matz, C. Bancher (Krems, Austria)

    Objective: This retrospective study aimed to assess the effect of Botulinum toxin A (BoNT-A) injections in the lower limbs of hemiparetic patients on gait parameters,…
  • 2023 International Congress

    Ultrasound-guided selective diagnostic nerve block in patients with elbow spasticity: a retrospective pilot study.

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: To evaluate efficacy and patients’ perception of the ultrasound-guided selective diagnostic nerve block (DNB) of the motor branch for brachialis muscle compared with the…
  • 2023 International Congress

    Improvement in spasticity-associated dressing- and hygiene-related disability in adults following treatment with incobotulinumtoxinA: a pooled analysis

    F. Molteni, J. Wissel, K. Fheodoroff, M. Munin, A. Patel, M. Althaus, G. Comes, A. Dekundy, I. Pulte, A. Scheschonka, M. Vacchelli, A. Santamato (Costa Masnaga, Italy)

    Objective: To evaluate impact of incobotulinumtoxinA (incoA) on dressing- and hygiene-related disability (DRE and HYG) in adults with upper-limb spasticity (ULS) based on pooled data…
  • 2022 International Congress

    Outcome measurement and goal setting recommendations in the multipattern treatment of shoulder spasticity with botulinum neurotoxin

    J. Jacinto, A. Camões Barbosa, S. Carda, D. Hoad, J. Wissel (Alcabideche, Portugal)

    Objective: To present expert consensus on choice of outcome measurement scales and goal setting recommendations for botulinum neurotoxin (BoNT) in the treatment of shoulder spasticity…
  • 2022 International Congress

    Transition from paediatric to adult care – A satisfaction survey of young people with complex motor disorders and implanted devices.

    S. Perides, L. Keenan, V. Stevenson, M. Kaminska (London, United Kingdom)

    Objective: The aim of this audit was to explore the satisfaction and experience of young people with implantable Intrathecal baclofen pumps transitioning to an adult…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley